TheHerpesTreatment.com is an informative website bringing to light the facts about herpes, and endorsing "Get Rid of Herpes" eBook for people who want to put an end to their condition using effective and affordable methods.
Read MoreSemprus BioSciences today announced it has received a $1 million grant from the U.S. Army Telemedicine & Advanced Technology Research Center (TATRC) to develop the world's first orthopedic devices designed to reduce biofilm formation.
Read MoreRandy Vader today announced the launch of IVD Consultants, a new consulting and contract firm. IVD Consultants will provide a wide range of Regulatory, Clinical and Quality consulting and contract services to the IVD and Medical Device industries.
Read MoreGeoVax has decided to expand its preventative HIV/AIDS vaccine development effort in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) and the HIV Vaccine Trials
Read MoreA new generation of rapid point-of-care tests for HIV and HEP B/C-such as those being developed by Chembio-could help ensure that donated organs are healthy, and that unfortunate incidents like the one reported in New York City do not reoccur.
Read MoreDr. Siddharth M. Jondhale, the young Doctor hailing from Nanded, Maharashtra (located in the Western part of India) working judiciously for the cure of the disease HIV, has been selected for the Albert Schweitzer Award.
Read MoreThe article, titled "Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles," will appear in the March 1 issue of The Journal of Infectious Diseases.
Read MoreNovaBay Pharmaceuticals, Inc., is innovating a new class of drugs, known as Aganocide® compounds, that mimic the body's natural defense against infection. The Aganocides could potentially equal or exceed the utility of antibiotics.
Read MoreAlcon and NovaBay will be analyzing the microbiological and clinical efficacy of the drug vs. placebo in all 81 adenovirus positive patients enrolled in the trial and plan to report on these analyses in early 2011.
Read MorePolyMedix, Inc, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis.
Read MoreOver 300,000 patients suffering from stroke and multiple sclerosis or spinal cord injuries resulting in quadriplegia or paraplegia use Foley catheters. These patients are at a daily risk for developing catheter-associated urinary tract infections.
Read MoreA dangerous new mutation that makes some bacteria resistant to almost all antibiotics has become increasingly common in India and Pakistan and is being found in patients in Britain and the United States who got medical care in those countries, accord
Read MoreAlthough the GeoVax vaccines are currently being studied for HIV prevention, this is the first study using the same products for treatment of persons who already have HIV infection. ARCA is the only site for this trial.
Read MoreThe Handwash Reminder can be an Infection Control Device that helps prevent the spread of viruses, diseases and bacterial infections. This product is also a great hand sanitation device. It automatically reminds you to wash your hands.
Read MoreDetection & Identification of Pathogens, Biological Threats and Infectious Diseases -
Detection Technologies is an internationally recognized event for experts in detection and identification of pathogens, biological threats and infectious diseases